Impact of BCR Stimulation on Mir-181b in Chronic Lymphocityc Leukemia

被引：0
|
作者：
Di Marco, Amerigo Mirco [1 ]
Autore, Francesco [2 ]
Lanuti, Paola [3 ]
Innocenti, Idanna [2 ]
Leone, Giuseppe [4 ]
Ramassone, Alice [5 ]
Veronese, Angelo [3 ]
Costantini, Renato Mariani [6 ]
Laurenti, Luca [2 ]
Visone, Rosa [3 ]
机构：
[1] Univ G DAnnunzio, CESI MET, Chieti, Italy
[2] Cathol Univ, Inst Hematol, Sacred Heart, Rome, Italy
[3] Univ G dAnnunzio, Chieti, Italy
[4] Hematol Univ Cattolica Sacro Cuore, Rome, Italy
[5] Univ G dAnunzio Chieti Pescara, CESI, Chieti, Italy
[6] Univ G dAnunzio Chieti Pescara, Chieti, Italy
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2026.2026
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2026
引用
收藏
页数：4
相关论文
共 50 条
  • [1] miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia
    Visone, Rosa
    Veronese, Angelo
    Rassenti, Laura Z.
    Balatti, Veronica
    Pearl, Dennis K.
    Acunzo, Mario
    Volinia, Stefano
    Taccioli, Cristian
    Kipps, Thomas J.
    Croce, Carlo M.
    BLOOD, 2011, 118 (11) : 3072 - 3079
  • [2] MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia
    Visone, Rosa
    Veronese, Angelo
    Balatti, Veronica
    Croce, Carlo M.
    ONCOTARGET, 2012, 3 (02) : 195 - 202
  • [3] CARD11 is a novel target of miR-181b that is upregulated in chronic lymphocytic leukemia
    Kou, Zhen
    Mao, Min
    Liu, Hong
    Wang, Xiaomin
    Wang, Zengsheng
    Gu, Zailinuer
    Lang, Tao
    Nie, Yuling
    Wang, Yichun
    Huang, Qin
    An, Li
    Zhang, Xiaoyan
    Fu, Lin
    Li, Yan
    BIOMARKERS IN MEDICINE, 2021, 15 (09) : 623 - 635
  • [4] miR-181b与肿瘤
    刘娟
    吴昌平
    蒋敬庭
    临床检验杂志, 2012, 30 (09) : 659 - 661
  • [5] Aberrant Expression of Mir-29b, Mir-181a and Mir-181b in T-Cell Acute Lymphoblastic Leukemia
    Gimenes-Teixeira, Hamilton L.
    Zanette, Dalila L.
    dos Santos, Guilherme Augusto S.
    Scheucher, Priscila S.
    Dalmazzo, Leandro F.
    Araujo, Amelia G.
    Falcao, Roberto P.
    Silva Junior, Wilson A.
    Rego, Eduardo M.
    BLOOD, 2009, 114 (22) : 1192 - 1192
  • [6] miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eμ-TCL1 mouse model
    Bresin, Antonella
    Callegari, Elisa
    D'Abundo, Lucilla
    Cattani, Caterina
    Bassi, Cristian
    Zagatti, Barbara
    Narducci, M. Grazia
    Caprini, Elisabetta
    Pekarsky, Yuri
    Croce, Carlo M.
    Sabbioni, Silvia
    Russo, Giandomenico
    Negrini, Massimo
    ONCOTARGET, 2015, 6 (23) : 19807 - 19818
  • [7] MiR-181b expression levels decreases during the progression of the Chronic Lymphocytic Leukemia: a new potential prognostic tool
    Visone, Rosa
    Veronese, Angelo
    Rassenti, Laura Z.
    Balatti, Veronica
    Taccioli, Cristian
    Kipps, Thomas J.
    Croce, Carlo M.
    CANCER RESEARCH, 2010, 70
  • [8] FAMLF is a target of miR-181b in Burkitt lymphoma
    Li, J. G.
    Ding, Y.
    Huang, Y. M.
    Chen, W. L.
    Pan, L. L.
    Li, Y.
    Chen, X. L.
    Chen, Y.
    Wang, S. Y.
    Wu, X. N.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2017, 50 (06)
  • [9] Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy
    Uribe Copier, Camila
    Leon, Luis
    Fernandez, Mauricio
    Contador, David
    Calligaris, Sebastian D.
    SCIENTIFIC REPORTS, 2017, 7
  • [10] Circulating miR-19b and miR-181b are potential biomarkers for diabetic cardiomyopathy
    Camila Uribe Copier
    Luis León
    Mauricio Fernández
    David Contador
    Sebastián D. Calligaris
    Scientific Reports, 7
12345